Macroscopic HematuriaHMUPNCT07312461
Causes and Management of Children Presenting With Macroscopic Hematuria in the Pediatric Emergency Department
An observational study of Macroscopic Hematuria, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
Macroscopic hematuria. is a common symptom, leading to numerous emergency department visits in children of all ages. It can be linked to many pathologies, and its management in the emergency department is not standardized. Read more about this study
- Who is it for?
- Ages Up to 17 years
- Conditions the study is for
- Macroscopic Hematuria
- How many people
- 100 participants
- Where
- 1 siteFrance
- Study dates
- 30 Sep 2024to Jan 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 17 years
- All sexes
- No healthy volunteers
- Child
Study population: Minor subject (<18 years old) presenting to the pediatric emergency department with gross hematuria
Who may be able to join
- Minor subject (<18 years old)
- Patient presenting to the pediatric emergency department with gross hematuria
Who cannot join
- Subject (and/or their parents) who expressed their opposition to participating in the study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service de Pédiatrie 1 - Réanimation - CHU de Strasbourg - France
Strasbourg, 67091
Ariane ZALOSZYC, MD, PhD, 33 3 88 12 77 42, ariane.zaloszyc@chru-strasbourg.fr
Ariane ZALOSZYC, MD, PhD
About this study
Macroscopic hematuria. is a common symptom, leading to numerous emergency department visits in children of all ages.
It can be linked to many pathologies, and its management in the emergency department is not standardized.
Few articles describe the management of this symptom during pediatric emergency department visits.
Therefore, it is important to study this symptom and its management in order to establish a protocol.
- Conditions
- Macroscopic Hematuria
- Keywords
- Macroscopic hematuria, Hematuria in children
What is being measured
The primary outcome is the main question the study is designed to answer.
Describe the different causes of this symptom
Measured: Up to 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Dec 2025
- Study start30 Sep 2024
- Primary completionJan 2026 (estimated)
- Study completionJan 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Macroscopic HematuriaStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07312461
- Sponsor's protocol ID
- 9456
- Acronym
- HMUP
- Status last verified
- Dec 2025
- First submitted
- 10 Dec 2025
- Last updated
- 31 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Causes and Management of Children Presenting With Macroscopic Hematuria in the Pediatric Emergency Department
- ClinicalTrials.gov ID
- NCT07312461
- Acronym / sponsor ID
- HMUP / 9456
- Conditions
- Macroscopic Hematuria
- Keywords
- Macroscopic hematuria, Hematuria in children
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 30 Sep 2024 (actual)
- Primary completion
- Jan 2026 (estimated)
- Study completion
- Jan 2026 (estimated)
- First posted
- 31 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Macroscopic hematuria. is a common symptom, leading to numerous emergency department visits in children of all ages.
It can be linked to many pathologies, and its management in the emergency department is not standardized.
Few articles describe the management of this symptom during pediatric emergency department visits.
Therefore, it is important to study this symptom and its management in order to establish a protocol.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- Up to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Minor subject (<18 years old) presenting to the pediatric emergency department with gross hematuria
Key inclusion criteria (2 listed)
- Minor subject (<18 years old)
- Patient presenting to the pediatric emergency department with gross hematuria
Key exclusion criteria (1 listed)
- Subject (and/or their parents) who expressed their opposition to participating in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Describe the different causes of this symptom
Time frame: Up to 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Dec 2025.
Related trials for Macroscopic Hematuria
Not yet recruiting
Air vs. Liquid: A Study on Cystoscopy Performance and Visibility Enhancement in Macrohematuria Cases
Macrohematuria
Active, not recruitingObservational study
Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Bladder Cancer, Urothelial Carcinoma Bladder
Not yet recruitingObservational study
Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test
Hematuria
RecruitingObservational study
Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?
Hematuria, Acute Cystitis With Hematuria
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Macroscopic Hematuria, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 31 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ariane ZALOSZYC, MD (33 3 88 12 77 42, ariane.zaloszyc@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Describe the different causes of this symptom (time frame: Up to 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2025.